Discover 1 curated intelligence briefings related to this specific topic.
For decades, liver fibrosis was viewed as a one-way street toward cirrhosis. Today, a paradigm shift in molecular therapy and a global reclassification of metabolic disease are turning the tide, shifting the medical goal from slowing decline to active biological reversal.